Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Realheart Total Artificial Heart Earns Humanitarian Use Exemption
OEM News

Realheart Total Artificial Heart Earns Humanitarian Device Designation

Realheart TAH is a total artificial heart that mimics the human heart’s structure and physiological function.

Real Heart AB announced that its Realheart TAH (total artificial heart) has been awarded Humanitarian Use Device (HUD) designation from the U.S. Food and Drug Administration (FDA).

The HUD status means that Ralheart TAH is eligible to apply for Humanitarian Device Exemption (HDE), which is an expedited regulatory pathway that can give the product limited marketing rights.

Realheart TAH is a total artificial heart that mimics the human heart’s structure and physiological function. The HUD status paves the way for the device to treat advanced biventricular heart failure in patients who have few other options and must be supported by a TAH.

HDE will be approved if the company can show data that indicates probable safety and benefit to the intended patient group. The company will continue communicating with the FDA to develop a clinical investigation strategy to support an HDE premarket approval.

“We are extremely pleased that Realheart TAH has been granted Humanitarian Use Device designation by the FDA,” said Ina Laura Perkins, CEO of Realheart. It is gratifying to look forward to our efforts culminating in such humanitarian benefit. We look forward to updating the market on further clinical and regulatory activities and meanwhile continue our preclinical development which will be important for potential future full market approval.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters